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Previewsand astrocytes, both of which suggest
a state of exaggerated inflammation that
at present is difficult to reconcile with a
requirement for granulin in innate immune
responses and particularly proinflamma-
tory cytokine production. Survival during
certain viral infections (notably infection
by mouse cytomegalovirus and other
herpesviruses) is strongly dependent on
TLR9 signaling and may be taken as
a sensitive indicator of TLR9 function.
The conclusion that granulin is a molecule
of central importance in signaling viral
invasion thus awaits further testing.
Taken together, the available data
suggest a hypothetical model in which
secreted granulin encounters and binds
to CpG-ODN, either extracellularly or
(more probably) in phagosomes (Figure 1).
Sortilin may function as the receptor for
granulin, constitutively transporting it toendolysosomes. When bound to CpG-
ODN or perhaps other TLR9 ligands,
granulin may serve to concentrate ligand
for optimal efficiency of receptor activa-
tion, as well as act as a cofactor for
TLR9 binding and activation. Future
studies will undoubtedly clarify the role
of granulin in TLR9 signaling.REFERENCES
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The molecular mechanism behind alum adjuvanticity is probably the oldest secret of immunology. In this
issue of Immunity, Kuroda et al. (2011) and Kool et al. (2011) identify NLRP3 inflammasome-independent
signaling to be crucial for the Th2 cell response induced by aluminum salts.Edward Jenner’s vaccination against
smallpox in 1789 is the first and still most
dramatic record of a successful manipula-
tion of the immune system. Early trials of
vaccine development revealed that the
efficiency of vaccines depends on the
presence of so-called adjuvants (Latin
adiuvare, to help) in conjunction with the
antigen. However, it took 200 years of
research until Charles Janeway proposed
the immunologic function of these little
helpers—to stimulate the innate immune
system. He suggested that adaptive
immunity was not raised until the innate
immune system provided clear evidence
for the presence of pathogens—or fordanger, as later extended by Polly
Matzinger. The concept of PAMPs (path-
ogen-associated molecular patterns) and
DAMPs (danger-associated molecular
patterns) triggering innate PRRs (pattern
recognition receptors) was born. The
signals triggered by PAMPs and DAMPs
strongly determine the type of adaptive
immunity, ensuring an effective clearance
of infection or appropriate inflammatory
responses to sterile tissue damage.
The most commonly used adjuvant in
humans is alum. It induces so-called
type 2 immune responses characterized
by eosinophilia and production of IL-4,
IgE, and IgG1. Although the discovery ofalum’s adjuvanticity dates back to 1926,
the underlying molecular mechanism is
still a matter of debate.
The discovery that the NLRP3 inflam-
masome senses particulates including
monosodium urate (MSU) crystals (Marti-
non et al., 2006), silica, and asbestos, as
well as alum (Dostert et al., 2008; Hornung
et al., 2008) suggested a plausiblemecha-
nism for alum’s effect as an adjuvant.
Cellular uptake of particulates leads to
reactive oxygen production and can
inflict lysosomal damage. Both of these
effects were suggested to act upstream
in the activation of NLRP3 (Dostert et al.,
2008; Hornung et al., 2008). Aluminum34, April 22, 2011 ª2011 Elsevier Inc. 455
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Figure 1. Mechanisms of Particulate-Induced Immunity: An Updated Model
Upon phagocytosis, particulates like aluminum salts or monosodium urate crystals (MSU) cause lysosomal damage. This initiates at least two separate
signaling pathways. First is the activation of the NLRP3 inflammasome resulting from the release of enzymes like cathepsin B into the cytoplasm. Autocata-
lytically activated caspase-1 mediates the proteolytic cleavage of pro-IL-1b in biologically active IL-1b, accounting for the inflammatory response to particu-
lates. Second is the activation of Syk, which in turn activates cytosolic phospholipase A2 (cPLA2), probably via p38 MAP kinase, resulting in the release
of arachidonic acid from membrane lipids. Cyclooxygenase-2 (COX-2) and membrane-associated PGE synthase-1 (mPGES-1) convert arachidonic acid to
prostaglandin E2 (PGE2).
Immunity
Previewssalt-mediated cytotoxicity can further
induce cell death with subsequent release
of uric acid (UA), which can also indirectly
activate the NLRP3 inflammasome (Kool
et al., 2008). Activated NLRP3 recruits
the adaptor molecule ASC, which binds
to and activates procaspase-1. Active
caspase-1 catalyzes the cleavage of
proforms of the IL-1b cytokine family into
biologically active cytokines (Martinon
et al., 2002). The crucial role of the
NLRP3 inflammasome for the secretion
of IL-1b cytokines is undoubted.However,
results are controversial when it comes to
the question of whether NLRP3 plays
a role in alum-induced adjuvanticity and456 Immunity 34, April 22, 2011 ª2011 Elsevinduction of type 2 immunity. Whereas
some studies found NLRP3, ASC, and
caspase-1 to be required for alum-
induced adjuvanticity (Eisenbarth et al.,
2008), others failed to observe a role of
NLRP3 (Franchi and Nu´n˜ez, 2008).
The studies from Kuroda et al. (2011)
and Kool et al. (2011) aimed to clarify the
molecular mechanisms by which immu-
nogenic particulates initiate type 2
immune responses. Both studies argue
for NLRP3-independent mechanisms.
Kuroda et al. (2011) suggest a crucial
involvement of prostaglandin PGE2. Kool
et al. (2011) identify UA as an essential
initiator and amplifier of alum- and houseier Inc.dust mite (HDM) allergen-induced type 2
immunity (Figure 1). Kuroda et al. (2011)
report the initiation of two separate
pathways upon stimulation with particu-
lates. As shown in previous studies, silica
and alum induced the secretion of IL-1b
cytokines in an NLRP3-dependent
manner. In addition, the particulates
induced the production of the proinflam-
matory arachidonic acid metabolite pros-
taglandin PGE2. This second pathway,
however, was independent of NLRP3,
ASC, and caspase-1, but depended
on cyclooxygenase-2 (COX-2) and
membrane-associated PGE synthase-1
(mPGES-1), whereas neither COX-2 nor
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production. Furthermore, antigen-
specific IgE amounts were reduced in
mPGES-1-deficient mice after immuniza-
tion with alum as an adjuvant. Conversely,
immunization with NiO, which causes the
secretion of PGE2 but not of IL-1b,
substantially enhanced IgE amounts.
These studies support a role of PGE2
rather than IL-1b in IgE production.
Intriguingly, the mechanisms that lead
to PGE2 production are very similar to
those that operate upstream of NLRP3
although the former process is NLRP3
independent. A priming step by a pro-
inflammatory stimulus is required (to
induce the expression of COX-2 and
mPGES-1), and the induction of lyso-
somal damage by the particulate acts as
a necessary second activation step.
Based on studies with inhibitors, the
authors further demonstrated that lyso-
somal damage leads to cPLA2 (cytosolic
phospholipase A2) activation, probably
via Syk and p38MAP kinase, finally result-
ing in the release of arachidonic acid from
membrane lipids and in the production of
PGE2.
The immunostimulatory effects of
particulates not only enable their use as
adjuvants, but they also account for
the role of particulates in inflammatory
diseases. In allergic asthma, for example,
particulates like HDM trigger a Th2 cell
response characterized by eosinophilic
airway inflammation, mucus hypersecre-
tion, and airway obstruction. In gout,
MSU crystals activate NLRP3 leading to
inflammation (Martinon et al., 2006).
Here, Kool et al. (2011) report a major
role for MSU in allergic asthma. Sensitiza-
tion of mice with OVA-alum or HDM
induced an allergic Th2 cell response
upon antigen challenge. This response
was characterized by eosinophilia, in-
creased Th2 cell cytokines and antibody
concentrations, as well as migration and
activation of inflammatory monocytes
and dendritic cells (DCs). Notably, uricase
treatment of mice just before sensitization
reduced Th2 cell immunity, suggesting
that MSU played a critical role in alum-
and HDM-induced asthma. Indeed, UA
amounts increased upon treatment of
mice with alum-OVA or house dust mite
allergen. Consistently, asthmatic patients
showed elevated UA concentrations after
allergen challenge. Sensitization of mice
with MSU-OVA revealed that MSU wasnot only necessary but also sufficient
for the induction of an allergic Th2 cell
response. Most notably, and in contrast
to the well-known inflammatory pathway
initiated by MSU in gout (Martinon et al.,
2006), the induction of Th2 cell immunity
by MSU did not require NLRP3, ASC, or
IL-1R.
As previously reported, elevated UA
amounts can reflect alum-induced cell
damage leading to the release of endoge-
nous DAMPs (Kool et al., 2008). In the
case of HDM, Kool et al. (2011) propose
yet another mechanism, which is the
enhanced production of UA resulting
from upregulation of xanthine oxidore-
ductase (XOR). The XOR gene promoter
region contains an NF-kB control
element. Strikingly, in contrast to UA
production upon alum treatment, UA
production upon HDM treatment was
TLR4 dependent, suggesting that XOR
upregulation might represent another
important TLR priming effect.
Based on the finding that uricase treat-
ment lost its profound effects if mice were
sensitized by intratracheal instillation of
OVA-pulsed DCs, the authors concluded
that MSU had to act upstream of DC
activation and recruitment. The molecular
pathway for activation involved Syk
and PI3Kv. Notably, previous studies
proposed that MSU was able to
directly engage cholesterol-rich cellular
membranes of DCs in a receptor-inde-
pendent manner and thereby triggered
the activation of Syk (Ng et al., 2008).
Together, the work of Kuroda et al.
(2011) and Kool et al. (2011) provide
another jigsaw piece in the understanding
of particulate-induced immunity. Accord-
ing to these authors, particulates not
only activate the NLRP3 inflammasome
to induce the secretion of IL-1b but
also stimulate innate immunity in an
NLRP3-independent manner (Figure 1).
This latter pathway appears to be crucial
for the initiation of Th2 cell immunity and
could account for the controversy
regarding whether NLRP3 is required for
alum’s adjuvant effect. Although repre-
senting two separate pathways, both
pathways might go back to one common
event induced by particulates, namely
lysosomal damage.
Although the herein discussed studies
represent a substantial step forward
toward solving the mystery of alum’s
adjuvanticity, we are still struggling withImmunitydepicting an exact molecular mechanism.
It is likely that multiple pathways are
involved and that triggering multiple
pathways may actually be part of alum’s
secret of success. Four mechanisms
have been proposed so far to explain the
utility of alum as an adjuvant. First is the
so-called depot effect, which refers to
a slow release of antigen leading to pro-
longed stimulation of the immune system.
Second, by converting soluble antigen
into a particulate form, its uptake could
be enhanced. Third, NLRP3 stimulation
induces inflammation. And finally is the
induction of type 2 immunity by NLRP3-
independent signaling (Kool et al., 2011;
Kuroda et al., 2011).
Our efforts to solve the oldest secret in
immunology have taught us a great deal
about our immune system and about
what it takes to be a good adjuvant. These
lessons have major implications for
rational vaccine design. A good part of
modern vaccines consist of purified
antigens in combination with exogenous
adjuvants. In order to achieve good
efficiency, the formulation has to ensure
efficient uptake of antigen in close
conjunction with the adjuvant, and the
choice of the adjuvant will strongly influ-
ence the type of the adaptive immune
response. Finally, we are starting to
recognize the great potential of effectively
targeting the innate immune system by
combining multiple stimuli. A current
approach to dually target TLR4 and
TLR7 with a nanoparticle-based vaccine
provides an excellent example of how to
gain effectiveness by making the secret
a bit dirtier (Rhee et al., 2011).
REFERENCES
Dostert, C., Pe´trilli, V., Van Bruggen, R., Steele, C.,
Mossman, B.T., and Tschopp, J. (2008). Science
320, 674–677.
Eisenbarth, S.C., Colegio, O.R., O’Connor, W.,
Sutterwala, F.S., and Flavell, R.A. (2008). Nature
453, 1122–1126.
Franchi, L., and Nu´n˜ez, G. (2008). Eur. J. Immunol.
38, 2085–2089.
Hornung, V., Bauernfeind, F., Halle, A., Samstad,
E.O., Kono, H., Rock, K.L., Fitzgerald, K.A., and
Latz, E. (2008). Nat. Immunol. 9, 847–856.
Kool, M., Soullie´, T., van Nimwegen, M., Willart,
M.A., Muskens, F., Jung, S., Hoogsteden, H.C.,
Hammad, H., and Lambrecht, B.N. (2008). J. Exp.
Med. 205, 869–882.
Kool, M., Willart, M.A.M., van Nimwegen, M.,
Bergen, I., Pouliot, P., Virchow, J.C., Rogers, N.,34, April 22, 2011 ª2011 Elsevier Inc. 457
Immunity
PreviewsOsorio, F., Reis e Souza, C., Hammad, H., and
Lambrecht, B.N. (2011). Immunity 34, this issue,
527–540.
Kuroda, E., Ishii, K.J., Uematsu, S., Ohata, K.,
Coban, C., Akira, S., Aritake, K., Urade, Y., and
Morimoto, Y. (2011). Immunity 34, this issue,
514–526.458 Immunity 34, April 22, 2011 ª2011 ElsevMartinon, F., Burns, K., and Tschopp, J. (2002).
Mol. Cell 10, 417–426.
Martinon, F., Pe´trilli, V., Mayor, A., Tardivel, A., and
Tschopp, J. (2006). Nature 440, 237–241.
Ng, G., Sharma, K., Ward, S.M., Desrosiers, M.D.,
Stephens, L.A., Schoel, W.M., Li, T., Lowell, C.A.,ier Inc.Ling, C.C., Amrein, M.W., and Shi, Y. (2008).
Immunity 29, 807–818.Rhee, E.G., Blattman, J.N., Kasturi, S.P., Kelley,
R.P., Kaufman, D.R., Lynch, D.M., La Porte, A.,
Simmons, N.L., Clark, S.L., Pulendran, B., et al.
(2011). J. Virol. 85, 315–323.Resistance to Mousepox Virus:
CD94 on a Special MissionStipan Jonjic1,* and Tihana Trsan1
1Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, B. Branchetta 20, 51000 Rijeka, Croatia
*Correspondence: jstipan@medri.hr
DOI 10.1016/j.immuni.2011.04.002
NK cells play a key role in the control of ectromelia virus. In this issue of Immunity, Fang et al. (2011)
demonstrate that the deletion of CD94 abolishes resistance to mousepox infection.Natural killer (NK) cells are key actors in
innate immunity. They protect the host
from many types of viral infections by
sensing proinflammatory cytokines in
their environment as well as changes in
the expression of major histocompati-
bility complex (MHC) class I and other
molecules expressed on the cell surface
during a viral insult. Effector functions of
NK cells are regulated by integrating
signals from their activating and inhibi-
tory receptors. The engagement of inhib-
itory NK cell receptors by MHC class I
molecules expressed by healthy cells
prevents their activation. On the other
hand, NK cells are activated either
through the engagement of their acti-
vating receptors or a lack of engagement
of their inhibitory receptors. Defusing NK
cells is critical for their survival, so over
time viruses have evolved a number of
strategies to evade NK cell control
(Lisnic et al., 2010). Virus-driven evolu-
tion of their natural hosts led to emer-
gence of mechanisms able to oppose
the viral immunoevasion. The best way
to achieve this goal would be selection
of activating NK receptors that specifi-
cally recognize virally infected cells.
Indeed, unlike their inhibitory counter-
parts, many of the activating NK cell
receptors bind to various molecular
determinants of infection and demon-strate certain types of specificity to vir-
ally encoded molecules.
The most studied example of a virus-
specific NK cell response is in C57BL/6
(B6) mice, which are constitutively
resistant to murine cytomegalovirus
(MCMV). These mice express Ly49H, an
activating receptor on their NK cells
that directly interacts with the MCMV
m157 protein, leading to recognition and
elimination of infected cells via cytolytic
mechanisms (Arase et al., 2002). Another
NK cell-dependent mechanism of MCMV
resistance has been described in MA/My
mice, whose activating Ly49P receptor
recognizes the MHC class I allele H2-Dk
bound to a viral protein encoded by the
m04 gene (Kielczewska et al., 2009). It
has to be pointed out that the specificity
of NK cell receptors to virally encoded
molecules is not restricted to herpes
viruses as shown by the fact that
NKp46- and NKp44-activating NK cell
receptors bind to influenza hemagglutinin
(Arnon et al., 2006).
Mousepox or ectromelia virus is
another virus whose pathogenesis is
tightly controlled by NK cells. It belongs
to Orthopoxviruses, a large family of
DNA viruses that includes, in addition to
ectromelia, the variola virus, a causative
agent of smallpox, as well as vaccinia
virus, cowpox virus, and monkeypoxvirus. Unlike several mouse strains that
are highly sensitive to mousepox, B6
mice are able to successfully cope with
mousepox infection without developing
symptoms of the disease. The important
role that NK cells play in the control of
ectromelia infection is best illustrated by
the fact that depletion of NK cells abol-
ishes the resistance of B6 mice to this
virus. In addition to reducing the viral
burden during the early course of infec-
tion, functional NK cells are required for
the generation of an optimal T cell
response (Fang et al., 2008). A dramatic
reduction of both CD8+ and CD4+ T cell
responses is observed in ectromelia-
infected mice depleted of NK cells,
possibly as a consequence of virus-
mediated eradication of dendritic cells.
Although it is well established that NK
cells play a key role in ectromelia virus
infection in B6 mice, the molecular
mechanism of the resistance and the
receptors involved has remained elusive
until now.
In this issue of Immunity, Fang et al.
(2011) explain the mechanism of resis-
tance of B6 mice to ectromelia virus
through the involvement of the CD94
receptor (Figure 1). CD94-NKG2 recep-
tors are composed of an invariant CD94
polypeptide, which forms a heterodimer
with either NKG2A, NKG2C, or NKG2E
